Genpharmasec Rights Issue Details 2024
Last updated August 22, 2026
This IPO News reference page covers “Genpharmasec Rights Issue Details 2024”. The page is organized around genpharmasec ltd rights issue details, genpharmasec ltd rights issue dates, genpharmasec ltd rights issue objective, genpharmasec limited financial information (restated), about company. IPO News presents the structured facts and tables in its own layout and wording.
Topics Covered
- Genpharmasec Ltd Rights Issue Details
- Genpharmasec Ltd Rights Issue Dates
- Genpharmasec Ltd Rights Issue Objective
- Genpharmasec Limited Financial Information (Restated)
- About Company
- Company Address
- Genpharmasec RI Registrar
Key Facts
- India's trusted financial research platform since 2015. Live IPO GMP, subscription data, allotment status, Rights Issues, NCDs and unbiased stock broker reviews.
- Full amount of Rs.1.75 per Equity Share is payable on application.
- To meet the expenses of the Issue.
- Genpharmasec Limited's revenue decreased by -6.56% and profit after tax (PAT) rose by 637.15% between the financial year ending with March 31, 2023 and March 31, 2022.
Data Tables
| Issue Size (Shares) | 27.69 Cr Shares |
|---|---|
| Issue Size (Amount) | ₹48.45 Cr |
| Face Value | ₹1 Per Share |
| Issue Price | ₹1.75 per share |
| Record Date | 9th Jan 2024 |
| Listing At | BSE |
| BSE Code | 531592 |
| Letter of Offer | |
| Online Application (Registrar & Transfer Agent) | |
| Entitlement | 1 Rights Equity Share(s) for every 1 fully paid-up Equity Shares held on Record Date |
| Terms of payment | Full amount of Rs.1.75 per Equity Share is payable on application. |
| Period Ended | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|
| Assets | 19.88 | 21.65 | 27.82 |
| Revenue | 25.62 | 27.41 | 21.64 |
| Profit After Tax | 1.12 | -0.21 | 1.26 |
| Net Worth | 29.91 | 28.78 | 28.99 |
| Reserves and Surplus | 28.78 | 28.99 | |
| Total Borrowing | 3.08 | ||
| Amount in ₹ Crore |
Source record: View original public source ↗